Raymond James Financial’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$137M Sell
3,212,810
-599,935
-16% -$26.8M 0.04% 437
2026
Q1
$184M Buy
3,812,745
+520,199
+16% +$24.3M 0.06% 299
2025
Q4
$160M Sell
3,292,546
-143,631
-4% -$7.12M 0.05% 338
2025
Q3
$162M Sell
3,436,177
-2,443,717
-42% -$118M 0.05% 328
2025
Q2
$284M Buy
5,879,894
+2,635,867
+81% +$135M 0.1% 189
2025
Q1
$180M Buy
3,244,027
+425,597
+15% +$23M 0.07% 267
2024
Q4
$136M Buy
+2,818,430
New +$143M 0.05% 337

Other funds holding SNY

Raymond James Financial's SNY Position: Q2 2026 in Review

Raymond James Financial reduced its Sanofi (SNY) stake by 16% in Q2 2026, selling an estimated $26.8M and leaving 3,212,810 shares worth $137M. The position accounts for 0.04% of the portfolio, ranked #437.

Raymond James Financial first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $284M in Q2 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Raymond James Financial held 3,212,810 shares of Sanofi worth $137M as of Q2 2026.
  • Raymond James Financial sold 599,935 Sanofi shares in Q2 2026, an estimated $26.8M.
  • Sanofi made up 0.04% of Raymond James Financial's portfolio in Q2 2026, its #437 holding.
  • Raymond James Financial first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Sanofi position peaked at $284M in Q2 2025.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.